Infectious disease
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for November 10, 2020.
Data from this study is expected to support U.S. authorization and approval for their vaccine.
President-elect Joe Biden hit the ground running this morning with the announcement of his transition team’s COVID-19 advisory board.
They caution that as more data is accumulated and analyzed, the efficacy percentage may shift. Nonetheless, it’s extremely promising and there were no serious safety signals.
It was relatively quiet in terms of COVID-19-related clinical trials, but there was still quite a bit of news for trials involving other indications. Here’s a look.
A multi-institutional research team has developed a nasal spray that effectively blocks absorption of the SARS-CoV-2 virus in ferrets with direct contact to infected animals.
There was a handful of positive clinical trial news reported today. Here’s a look.
Harvard immunology experts comment on studies regarding antibodies in COVID-19 patients diminishing over time.
When it comes to a novel virus like SARS-CoV2, a certain amount of “rolling with the punches” is required, and governments and global organizations like the World Health Organization are beginning to dismiss certain treatments and devote themselves wholeheartedly to others.
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
PRESS RELEASES